This chapter presents the techniques and procedures for collecting samples for certain laboratory tests ([TABLE 2-1](#cetable1){ref-type="table"}, [TABLE 2-2](#cetable2){ref-type="table"}, [TABLE 2-3](#cetable3){ref-type="table"}, [TABLE 2-4](#cetable4){ref-type="table"} ). Normal values and interpretative guidelines are included. (For normal physiologic values, see Appendix I.)TABLE 2-1Endocrine AssaysTESTPROTOCOLSAMPLE REQUIREDNORMAL VALUESINTERPRETATION OF ABNORMAL VALUESBasal T~3~, T~4~Serum*Dog:* T~3~= 80-200 ng/dLSuggestive of hypothyroidism:= 0.8-2 ng/mL*Dog*:T~3~\< 30 ng/dL= 1.2-3.1 nmol/LT~4~\< 1 μg/dLT~4~= 1.3-4 μg/dLHyperthyroidism:= 13-40 ng/mL*Cat*:T~3~ \> 200 ng/dL= 20-52 nmol/LT~4~ \> 5 μg/dL*Cat:* T~3~= 60-150 ng/dL*Dog*:T~3~ \> 290 ng/dL= 0.6-1.5 ng/mLT~4~ \> 4 mg/dL= 0.6-1.9 nmol/LT~4~= 1-4.5 μg/dL= 10-45 ng/mL= 15-58 nmol/LFree T~4~ (FT~4~) by dialysisSerum*Dog:* 16-30 pmol/L*Cat:* 15-48 pmol/L*Dog:* FT~4~ \< 16 pmol/L suggestive of hypothyroidism, but may accompany other diseases*Cat:* FT~4~ \> 48 pmol/L indicative of hyperthyroidismTSH response test*Dog:* 0.1 IU TSH/kg IV *(Thytropar);* TSH inconsistently availableMeasure serum T~4~ at 0 and 4 or 6 hr after TSHPost-TSH T~4~ ≥ 2 × basal T~4~ or \>35 nmol/LPost-TSH T~4~ \< 2 × basal T~4~ or \< 35 nmol/L diagnostic of hypothyroidismCanine endogenous TSHSerum*Dog*:2-30 μU/LPrimary hypothyroidism: T~4~ decreased, TSH increased (20-30 ng/mL)2.7-7.9 ng/mLCanine assay validated for catsTRH stimulation test*Dog:* 0.2 mg TRH IV*Cat:* 0.1 mg TRH IVMeasure serum T~4~ at 0 and 4 hr after TRH*Dog:* Post-T~4~ \> 2 μg/dL or \> basal T~4~ + 0.5 μg/dL*Cat:* Post-T~4~ increased by \> 60%Hypothyroidism (dog): Post-T~4~ \< 0.5 4g/dLHyperthyroidism (cat): Post-T~4~ increased by \< 50%Equivocal findings (cat): Post-T~4~ elevation of 50%-60%T~3~ suppression test*Cat:* 25 μg T~3~ PO TID × 7 dosesMeasure T~4~, T~3~ before and 2-4 hr after last dose of T~3~T~4~ ≤ 15 ng/mLHyperthyroid cats: T~4~ does not suppress≤ 20 nmol/LHigh T~3~: confirms administration of T~3~ACTH response testA.Synthetic ACTH *(Cortrosyn)Dog:* 0.5 U/kg IV, IM (max = 20 U)*Cat:* 0.125-0.25 mg IV, IMB.*Dog or cat:* ACTH gel2.2 U/kg IMA.Measure serum cortisol at 0 and 1 hr after ACTH in dogs or at 0, 30, and 60 min in catsB.Measure serum cortisol at 0 and 2 hr after ACTH in dogs and at 0, 1, and 2 hr in cats≤ 50% of pretreatment values*Dog:* Pre-ACTH = 1.1-5 mg/dL, 25-38 nmol/LPost-ACTH = 6.2-16.8 mg/dL, 200-500 nmol/L*Cat:* Pre-ACTH = 0.33-2.6 μg/dL, 15-72 nmol/LPost-ACTH = 4.8-7.6 μg/dL, 130-210 nmol/LHyperadrenocorticism:Pre-ACTH = 4-10.8 μg/dLPost-ACTH = 11.7-50 μg/dLPrimary hypoadrenocorticism:Pre- and post-ACTH = ≤1 μg/dL, ≤30 nmol/LACTH assayDraw sample into chilled syringe and insert into chilled EDTA tube; transfer sample to plastic tube and cool for 20 min in ice water; centrifuge sample for short time, retrieve plasma into another plastic tube, and Trasylol; freeze sample immediately and transport on dry ice*Dog:* 20-80 pg/mL (avg. 45)2-8.8 pmol/L*Cat:* 20-61 pg/mL1-20 pmol/LPituitary-dependent hyperadrenocorticism:ACTH ≥40-500 pg/mL\>88 pmol/LFunctional adrenal tumor:ACTH ≤20 pg/mL≤4.4 pmol/LLow-dose dexamethasone suppression test0.01 mg/kg dexamethasone sodium phosphate IVMeasure serum cortisol at 0, 4, and 8 hr after dexamethasone*Dog:* Pre = 1.1-5 μg/dL Post = \<1 μg/dL (Normal dogs suppress)Hyperadrenocorticism: no suppression 4 or 6 hr post: 30% of pituitary-dependent hyperadrenocorticism cases suppressHigh-dose dexamethasone suppression test0.1 mg/kg dexamethasone sodium phosphate IVMeasure serum cortisol at 0, 4, and/or 8 hr after dexamethasonePre values reflect hyperadrenocorticism (4-10.8 μg/dL)8 hr post: \>1 μg/dL, \>30 nmol/LUrine cortisol:creatine ratioFresh urine sampleUrine cortisol (nmol/L):urine creatinine (mmol/L) ratio ≥35 (dog), \<28 (cat)Ratio \> normal is suggestive of hyperadrenocorticismInsulin assayMeasure serum insulin after 24-hr fast or during episodes of hypoglycemia6-22 μU/mLValues \< normal preclude diagnosis of insulinomaValues \> normal are suggestive of insulinomaGH assaySerum; assay currently unavailable*Dog:* 0-10 ng/mL (usually 2-3 ng/mL)*Cat:* 0-8.5 ng/mL (mean = 1.21 ± 1.0 ng/mL)Values \> 90 ng/mL have been associated with neoplasia causing diencephalic syndrome in the dog and acromegaly in the catLow values are difficult to asses; stimulation tests should be performedClonidine stimulation test10 μg clonidine kg IV *(Catapresan)*Measure plasma GH at 0, 15, 30, 45, 60, and 120 min after clonidine; keep samples frozen until assayed; GH assay currently unavailableNormal dogs show increase in GH between 15 and 45 min with a peak of 25-40 ng/mLClonidine is a GH stimulant; pituitary dwarfs demonstrate either no or little response to clonidineXylazine stimulation test100 mg/kg IV *(Rompun)*Measure plasma GH at 0, 15, 30, 45, 60, and 120 min after xylazine; keep samples frozen until assayed GH assay currently unavailableNormal dogs show increase in GH between 15 and 45 min with a peak of 25-40 ng/mLPituitary dwarfs show no response to xylazineSomatomedin-C; IGF-1Serum*Dog:* 280 ± 23 ng/mL (adults)345 ± 50 ng/mL (immature dogs)5-45 nmol/LPituitary dwarfs have low value (11 ± 2 ng/mL or \<5 nmol/L)Acromegaly in cats:Values of 70-100 nmol/L are nondiagnostic; repeat in 3 mosValues \> 100 nmol/L are diagnosticGastrin assayPlasma after 12-hr fast*Dog:* 45-125 pg/mL*Cat:* 28-135 pg/mLPlasma gastrin levels are increased with primary gastrointestinal tract disease (e.g., functional gastrinomas) or secondary to other systematic diseases, especially chronic renal failureAntidiuretic hormone response testPerform water deprivation test first; give desmopressin acetate 2-4 drops intra- nasally or conjunctivally or 10-20 mg/kg SC (dogs); if available, aqueous vasopressin may be given at 2-5 UIM (dogs)Empty bladder and collect urine at 60, 120, 180, and 240 minNormal: sp. gr. \>1.025Central diabetes insipidus: sp. gr. \>1.015Nephrogenic diabetes insipidus or medullary washout: sp. gr. \<1.015PTH assaySerum*Dog:* 2-13 pmol/L, 16-136 pg/mL*Cat:* 0-4 pmol/L, 3.3-22.5 pg/mLHypoparathyroidism: PTH is low or undetectable, especially if ionized calcium is lowParathyroid adenoma: PTH as high as 45 pmol/LSecondary hyperparathyroidism (renal failure): PTH grossly elevatedCalcitonin assayPlasma*Dog:* ≤25 pg-Eq/mLValues of plasma calcitonin are difficult to interpret at this time; extreme elevations may be caused by calcitonin-producing thyroid tumorsErythropoietinSerum*Dog:* 5-15 mU/mL*Cat:* 5-22 mU/mLLow: primary polycythemia, chronic renal failureNormal or high: secondary polycythemiaVery elevated: asplastic anemia, certain renal tumorsIonized calciumSerum1.12-1.42 nmol/LPrimary hyperparathyroidism: increased valuesMalignant hypercalcemia; increased valuesRenal failure: normal or increased valuesHypoparathyroidism: decreased valuesFeline pancreatitis: decreased values[^1][^2][^3]TABLE 2-2Gastrointestinal StudiesTESTPROTOCOLSAMPLE REQUIREDNORMAL VALUESINTERPRETATIONBile acid assays1.Fast animal 12 hr2.Feed a routine or high-protein mealSerum samples are colleted after 12-hr fast and 2 hr after a meal*Dog:* Fasting ≤5 mmol/LPostprandial ≤ 15.5 mmol/L*Cat:* Fasting ≤ 2 mmol/LPostprandial ≤ 10 mmol/LElevations indicate dysfunction of normal hepatobiliary physiology, with the degree of elevation providing limited quantitative informationAmmonium tolerance testGive 100 mg/kg NH~4~Cl PO (max dose = 3 g)1.Draw blood sample into EDTA or heparinized saline before and 30 min after NH~4~Cl2.Cool blood on ice immediatelyFasting ≤ 120-150 μg/dLPost-NH~4~Cl ≤ 200-250 μg/dLElevation of blood ammonia indicates either hepatic dysfunction or shunting of portal blood away from the liver (i.e., portocaval shunt)Glucagon tolerance test1.Fast animal 2 hr2.Give glucagon 0.03 mg/kg IVMeasure serum glucose at 0, 15, 30, 60, and 90 min after glucagon administrationSerum glucose rises in response to glucagon, with peak at 15 min, and returns to normal by 90 minGlucose curve remains flat with severe hepatic insufficiency, portocaval shunt, glycogen storage disease, and prolonged anorexia or starvationBT-PABA test1.Fast animal 18 hr2.Give 5 mL 1% BT-PABA/kgPO followed by 25-100 mL water3.Stomach tubing is preferred4.Avoid concurrent use of chloramphenicol, sulfonamides, diuretics, and pancreatic extracts for 5 days before testHeparinized plasma is obtained for measuring plasma PABA at 0, 30, 60, 90, and 120 min*Dog:* \>5-35 mg/mL*Cat:* \>7.5 mg/mL (at 90 min)Indirectly measures chymotrypsin activityValues \<1.25 mg/mL are compatible with pancreatic exocrine insufficiency and also reflect small intestinal absorption capabilitesValues of 1.25-4 mg/mL are compatible with malabsorptionTLI; canine (cTLI) and feline (fTLI) assays availableFast animal 6-12 hrSerum*Dog:* 5-35 μg/L*Cat:* 17-49 μg/LMaldigestion (exocrine pancreatic insufficiency): \<2 μg/L (dog), \<8 μg/L (cat)Malabsorption: \>5 μg/L (dog)Pancreatitis: \>50 μg/L (dog) \>200 μg/L (cat)PLIFast animal 6-12 hrSerum*Dog:* 0-200 μg/L*Cat:* 2-6.8 μg/LPoor diagnostic accuracy for pancreatitisPancreatitis: \>400 μg/L (dog) \>12 μg/L (cat)Fecal alpha 1-protease inhibitor assayCollect fresh fecal specimensFeces*Dog:* 0-32 μg/gIncreased with protein-losing enteropathiesFolate levelsFast animal 6-12 hrSerum*Dog:* 6.7-17.4 μg/L*Cat:* 13-4-38 μg/LIncreased with gastrointestinal bacterial overgrowth, pancreatic exocrine insufficiency, folate supplementation, or hemolyzed blood samplesLow with small intestine malabsortionCobalamin levelsFast animal 6-12 hrSerum*Dog:* 225-660 ng/L*Cat:* 200-1680 ng/LLow with cobalamin malabsorption (ileal disease), pancreatic exocrine insufficiency, or small intestinal bacterial overgrowthIncreased with parenteral supplementation[^4][^5]TABLE 2-3Renal Function TestsTESTPROTOCOLSAMPLE REQUIREDNORMAL VALUESINTERPRETATIONPSP excretion in urineA.1. Empty bladder via catheterization2.Give 6 mg PSP IVB.Give 1 mg PSP/kg IVA.Catheterize bladder 20 min later and collect all urineB.Collect 4 mL heparinized plasma before and 60 min after PSP administrationA.Normal: \>30% excretion of PSPB.Normal: 80 μg/dLSuspicious: 80-120 μg/dLAbnormal: =120 μg/dLA.Assesses renal blood flowB.Assess renal tubular function; abnormal retention occurs with renal insufficiencySS clearanceGive 0.2 mL of 10% solution/kg IV after a 12-hr fastObtain heparinized blood at 30, 60, and 90 minResults are expressed as the time needed to clear 50% of dye from the blood (t~1/2~)Normal t~1/2~ = 32-84 min.SS retention in plasma above normal reflects diminished GFRSS clearance is usually reduced before the development of either azotemia or urine concentration defectsEndogenous creatinine clearance1.Acclimate animal to metabolism cage2.Catheterize and empty bladder3.Allow access to free-choice water4.Collect all urine for 24 hr; empty bladder again at end of test5.Avoid contamination of urine with feces6.Store urine in closed, refrigerated container until test is concluded7.Record total volume of urine1.Submit serum sample obtained midway through test for creatinine assay (SC)2.Submit urine sample from the pooled collection for creatinine measurement (UC)3.Use equation to calculate clearance:$$\text{GFR} = \frac{\text{UC}\left( {\text{mg}/\text{dL}} \right) \times \text{urine}\,\text{volume}\left( \text{mL} \right)}{\text{SC}\left( {\text{mg}/\text{dL}} \right) \times 1440\,\min \times \text{weight}\left( \text{kg} \right)}$$Normal, dogs: 2-5 mL/min/kgNormal, cats: 1.6-4 mL/min/kgDecreased GFR occurs with decreased renal blood flow (prerenal), obstruction of urine outflow (postrenal), and renal parenchymal diseaseDecreased GFR in an otherwise normal dog indicates renal insufficiencyUrine protein quantitationFollow protocol outlined for endogenous creatinine clearanceMost common assay is trichloroacetic acid-- ponceau S method1.Submit pooled urine sample2.Protein excretion/24 hr = urine protein (mg/dL) × urine volume (dL)3.Protein excretion/kg = total protein (mg)/weight (kg)1.Protein/kg/day ≤30 mg/kg/day2.Total protein:333 ± 309 mg/daySignificant proteinuria occurs with glomerular diseaseOther causes include Bence Jones proteinuria, myoglobinuria, and severe urinary tract traumaUP/C ratioRandom sample*Dog:* urineNormal ≤1.0Significant proteinuria: UP/C \>1.0Results are affected by both pyuria and gross blood contamination[^6]TABLE 2-4Interpretation of Selected Serologic TestsDISEASETESTINTERPRETATIONBrucellosisA.RSATA.Good screening testFalse positives occur, so perform further seologic assay to confirm the diagnosis; a modification of the test (ME-RSAT) using a less mucoid (M-) variant of *Brucella canis* has fewer false positives; it becomes positive within 3-4 wk, but false negatives can occur up to 8 wkB.Tube agglutination tests1.TATB.Most common confirmatory test1.Becomes positive by 3-6 wkTiter results:1:50 = early or recovering infection1:50-1:100 = suspicious≥1:200 = active infectionOccurrence of false positives similar to RSAT2.ME-TAT2.Fewer false positivesBecomes positive 1-2 wk after TAT or 5-8 wk post-infection≥1:200 = active infectionC.AGIDC.Becomes positive in 8-12 wkVery specific; used to confirm diagnosis, especially in chronic casesBoth somatic and cytoplasmic (CPAg-AGID) tests available, but somatic rarely usedResults reported as positive, suspicious, or negativeRepeat in 4-6 wk if first results are suspiciousMay remain positive for 1 yrD.ELISAD.Very specific, but less sensitive than TAT testsBecomes positive by 4 wkE.IFAE.Sensitivity is uncertain, so some infected dogs may be missedLeptospirosisA.MATA.Titers \<1:400 may be postvaccinalTiters \>1:800 usually indicate infectionPaired samples 2-4 wk apart are tested; a fourfold increase in titer is diagnosticTests for serovar groups, not individual serovarsB.ELISAB.IgM titer: develops after 1 wkIgG titer: develops in 2-3 wkVaccinates: high IgG titer with low or negative IgM titerFeline infectious peritonitis (FIP)A.IFA, ELISAA.Titer \>1: 1600 (most laboratories) or fourfold increase over 2-4 wk is compatible with a positive diagnosisTiter \> 1: 240 is inconclusive [note]{.smallcaps}: This titer cross-reacts with other feline coronaviruses, so is not specific for FIPB.PCR assayB.May help confirm presence of coronavirus in seronegative cats, but false negatives can occur and is not specific for FIPCanine parvovirusA.Hemagglutination inhibition, ELISAA.Positive diagnosis:Single high IgM titerFourfold rise in IgG titer over 2-4 wk; also considered protectiveB.Fecal ELISA or hemagglutinationB.Sensitive and specific testShedding of virus is brief and usually not detected by day 10-12 of infection (day 5-7 of clinical illness)Vaccination produces false positives 5-12 days after administrationEhrlichiosis *(Ehrlichia canis)*A.IFAA.Becomes positive in 7-28 daysTiter \>1:80 is considered positive in endemic areasAny measurable titer (\>1:10) is significant in dogs in nonendemic areasSubmit a second sample 2-3 wk later if suspicious case is negative on first sampleTiters persist for 6-9 mo after infectionCross-reactivity occurs with *Neorickettsia* spp., *Helminthoeca* spp., and other ehrlichial agentsB.Western immunoblotting assayB.Detects antibodies 2-8 days after exposureCan distinguish *E. canis* from *E. ewingii*C.PCR assayC.Positive within 4-10 daysIn the future, it may be able to distinguish active infection from titers that persist following successful treatment of diseaseRocky Mountain spotted feverA.Indirect immunofluorescence test (Micro-IF) or ELISA for IgGA.Submit acute and convalescent titers 2-3 wk apartTiter ≤1:64 = normalTiter ≤1:1024 in East, ≤1:25 in West = infectedFourfold increase in titers is diagnosticFalse negatives occur early in diseaseTiters may stay elevated (1:128) for 5-10 moB.Micro-IF or ELISA for IgMB.Decreases within 4-8 wkSingle high titer indicates active infectionC.Latex agglutinationC.Sensitivity lower than Micro-IF testsSingle high titer (≤132) is diagnosticD.PCR assayD.Can be run on both whole blood and tissuesNested PCR more sensitive in treated dogsBorreliosis (Lyme disease)A.IFA, ELISAA.Titers are difficult to interpret and may indicate exposure rather than active infectionCan cross-react with other bacteria, especially other *Borrelia* spp. and *Leptospira* spp.Symptomatic dogs usually have titers \>1:128Measure IgG and IgM titers simultaneouslyFourfold increase in paired samples submitted 2-4 wk apart is supportiveIgG titers become positive in 4-6 wk and persist for ≤2 yrIgM titers may persist for several monthsTiters do not distinguish postvaccinal responses from actual infectionB.Western immunoblotting assayB.Can distinguish postvaccinal responses from actual exposure/infection and identify false negativesC.ELISA for specific outer surface proteins (Osp)C.Antibodies to OspA and OspB indicate post-vaccinal responseAntibodies to OspC indicate active infectionC~6~ assay way indicate active infection and help assess response to treatmentToxoplasmosisA.IHAA.Becomes positive in 2 wk; detects IgGRelatively insensitive, not species specificFourfold rise in titer over 2-3 wk supportiveB.LAT, MATB.Become positive in 2 wk, detects IgGMAT more sensitivePositive results: LAT \> 1:64MAT \> 1:100Fourfold rise in titer over 2-3 wk supportiveTest may be applied to aqueous humor or CSFC.IFA for IgM, IgGC.False positives occurIgM elevated within 1-2 wk and IgG detectable after 2 wkSingle high IgM titer (1:64), with negative IgG titer, implies active infectionFourfold increase in titers over 2-5 wk supportiveTest may be applied to aqueous humor or CSFD.ELISA for IgM, IgGD.More sensitive than IHA or LATIgM titer \>1.256, with negative IgG titer, implies active infectionIgM is detected within 1-2 wkIgG is detectable in approximately 2-4 wkFourfold increase in titers over 2-3 wk supportiveTest may be applied to aqueous humor or CSFE.All testsE.note: Use caution when interpreting results; antibodies can occur in the sera of both healthy and diseased cats; therefore serologic tests alone do not confirm the presence of disease; titers may persist for months to years following infectionBlastomycosisA.AGIDA.If positive, dog has 91% chance of having active disease but test may be negative in acute stagesB.ELISAB.May be more sensitive than AGID in catsAccuracy and sensitivity poorly definedCryptococcosisA.LATA.*Cat:* Titer \>1:12 indicative of active infection*Dog:* Any positive result indicative of infectionFalse negatives can occur with localized diseaseFalse positives possible with contamination of assay; test cross-reacts with *Trichosporon* spp.Titers correlate well with extent and course of disease, and response to therapyMay be assayed in serum, urine, CSFB.PCRB.May be performed on tissuesMay be assayed in serum, urine, CSFCoccidioidomycosisA.TP testA.Becomes positive in 2-6 wkDetects IgM; is a qualitative test and fades quickly (within 4-6 wk)B.CF testB.Detects IgG and appears in 8-10 wkTiter ≥1:4 = negativeTiter ≥1:16 = suspicious, chronic, or localized diseaseTiter =1:32 = active diseaseRise or drop in titer corresponds well with clinical course, but titers remain elevated for months after treatment or disease arrestC.LATC.Measures IgM, so detects acute infectionSome false positives in dogsD.AGID-TP, AGID-CFD.More sensitive assaysAGID-TP detects IgM; AGID-CF detects IgGE.ELISAE.Available for detection of both IgM and IgGSome false positives in dogs; cross-reacts with blastomycosisHistoplasmosisA.CF titerB.Skin histoplasmin testNeither test is considered reliable in dogs and cats for definitive diagnosisAspergillosisA.AGDDB.CIEC.ELISAD.PCR assayA.False positive rate of 6%; cross-reacts with *Penicillum* spp.B.Up to 15% false-positive resultsC.Less reliable than AGDD or CIED.Used experimentally; clinical availability limited [note]{.smallcaps}: Some infected dogs never seroconvert; false negative rate is higher when only one antigen tested[^7][^8][^9]

ANION AND OSMOLAL GAPS {#cesec1}
======================

Anion Gap {#cesec2}
---------

###  {#cesec3}

#### Definition {#cesec4}

I.By the law of electroneutrality, the concentration of circulating anions equals that of circulating cations.II.Cations and anions are classified as measured or unmeasured.A.Measured1.Anions: Cl^−^, HCO~3~ ^−^2.Cations: Na^+^, K^+^B.Unmeasured1.Anions (UA): albumin, α- and β-globulins, PO~4~ ^3--^, SO~4~ ^2--^, organic acids, certain toxins and drugs2.Cations (UC): gamma globulins, Ca^2+^, Mg^2+^, certain drugsC.In electroneutrality:$$\text{Na}^{+} + \text{K}^{+} + \text{UC} = \text{Cl}^{-} + \text{HCO}_{3}^{-} + \text{UA}$$III.Anion gap is the difference between measured cation and anion concentrations.A.Denotes an alteration in some unmeasured component of the equationB.Anion gap = (Na^+^ + K^+^) -- (Cl^−^ + HCO~3~ ^−^)1.Normal: 12 mEq/L; range: 8 to 16 mEq/L2.May be increased by either a decrease in UC or an increase in UA3.Is decreased by either an increase in UC or a decrease in UA4.Potassium sometimes deleted from equation because of its low, constant concentration

#### Causes {#cesec5}

I.Causes of increased anion gapA.Increase in UAB.Increase in serum lactate, ketoacids, and uremiaC.Certain medications: carbenicillin, penicillinD.Dehydration: concentrated normal anionsE.AlkalemiaF.Decrease in UC concentrations: Ca^2+^, Mg^2+^G.Increase in serum albuminH.Toxins: ethylene glycol, methanol, salicylate, paraldehydeII.Causes of decreased anion gapA.Increase in normal cations, especially Ca^2+^, Mg^2+^, and globulinsB.Retention of abnormal cations (e.g., multiple myeloma)C.Loss of UA: hypoalbuminemia

#### Clinical Significance {#cesec6}

I.Increases index of suspicion that unexpected (or unmeasured) cations or anions are present in serumII.Allows further definition and classification of metabolic acidotic statesA.Metabolic acidosis with normal or decreased anion gap is usually caused by renal or intestinal loss of bicarbonate (hyperchloremic acidosis).B.Metabolic acidosis associated with an increased anion gap may have various causes.1.Diabetic ketoacidosis2.Lactic acidosis3.Ethylene glycol or paraldehyde intoxication4.Acute renal failure

Osmolal Gap {#cesec7}
-----------

###  {#cesec8}

#### Definition {#cesec9}

I.Osmolal gap is the difference between measured serum osmolality and calculated osmolality.II.Serum osmolality can be measured with an osmometer.A.The major osmotically active solutes are Na^+^, K^+^, glucose, and urea (measured as blood urea nitrogen \[BUN\]).B.Normal osmolality is 285 to 300 mOsm/kg.III.Calculated serum osmolality is derived from the following equation:$$2\left( {\text{Na}^{+} + \text{K}^{+}} \right) + \frac{\text{Glucose}}{18} + \frac{\text{BUN}}{3}$$IV.A difference of \>10 mOsm between the measured and calculated values is significant.

#### Causes {#cesec10}

I.If the calculated value exceeds the measured value, a mathematical or laboratory error exists.II.If the measured value is normal but the calculated value is low, a decrease in serum water is the usual cause.III.An unmeasured osmole is suggested when both values are elevated and a significant gap exists.A.Mannitol, glycerinB.Sorbitol, acetoneC.Ethylene glycol, alcoholD.Myeloma protein, hyperlipidemiaE.Infused hyperosmotic solutionsF.Activated charcoal containing propylene glycol and glycerol ([@bib4])

#### Clinical Significance {#cesec11}

I.Directs attention to laboratory errorsII.Detects presence of unmeasured osmoles (e.g., ethylene glycol)III.Can be used to confirm hyperproteinemia and hyperlipidemia

[^1]: *T~3~,* Triiodothyronine; *T~4~,* thyroxine; *TSH,* thyroid-stimulating hormone; *TRH,* thyroid-releasing hormone; *ACTH,* adrenocorticotropic hormone; *max,* maximum.

[^2]: *EDTA,* Ethylenediamine tetraacetic acid; *GH,* growth hormone.

[^3]: *IGF-1,* Insulin-like growth factor-I; *sp. gr.,* specific gravity; *PTH,* parathormone.

[^4]: *BT-PABA, N*-benzoyl-L-tyrosyl-p-aminobenzoic acid; *TLI,* trysin-like immunoreactivity.

[^5]: *PLI,* Pancreatic lipase immunoreactivity.

[^6]: *PSP,* Phenolsulfonphthalein; *SS,* sodium sulfanilate; *GFR,* glomerular filtration rate; *UP/C,* urine protein:creatinine.

[^7]: *RSAT,* Rapid slide agglutination test; *TAT,* tube agglutination test; *ME-TAT,* 2-mercaptoethane TAT; *AGID,* agar-gel immunodiffusion; *ELISA,* enzyme-linked immunosorbent assay; *IFA,* indirect immunofluorescence antibody; *MAT,* microscopic agglutination test; *IgM,* immunoglobulin M; *IgG,* immuoglobulin G; *PCR,* polymerase chain reaction; *FIP,* feline infectious peritonitis.

[^8]: *IHA,* Indirect hemagglutination; *LAT,* latex agglutination test; *CSF,* cerebrospinal fluid.

[^9]: *TP,* Tube precipitin; *CF,* complement fixation; *AGDD,* agar gel double diffusion; *CIE,* counterimmunoelectrophoresis.
